Dr. Reddy's Laboratories Limited

NYSE: RDY
New York Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#1592
Country Rank
#90
Market Cap
$12.6 B
Price
$15.08
Change (%)
1.34%
Volume
583,438

Dr. Reddy's Laboratories Limited's latest marketcap:

$12.6 B

As of 07/03/2025, Dr. Reddy's Laboratories Limited's market capitalization has reached $12.6 B. According to our data, Dr. Reddy's Laboratories Limited is the 1592th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap $12.6 B
Revenue (ttm) $3.81 B
Net Income (ttm) $661.75 M
Shares Out 832 M
EPS (ttm) $0.79
Forward PE 18.94
Ex-Dividend Date 07/30/2024
Earnings Date 07/28/2025
Market Cap Chart
Data Updated: 07/03/2025

Dr. Reddy's Laboratories Limited's yearly market capitalization.

Dr. Reddy's Laboratories Limited has seen its market value grow from $1.58 B to $12.6 B since 2001, representing a total increase of 699.49% and an annual compound growth rate (CAGR) of 9.25%.
Date Market Cap Change (%) Global Rank
07/03/2025 $12.6 B -5.72% 1592
12/31/2024 $13.17 B 13.66% 1353
12/29/2023 $11.59 B 34.54% 1430
12/30/2022 $8.61 B -20.82% 1702
12/31/2021 $10.88 B -8.18% 1685
12/31/2020 $11.85 B 75.79% 1399
12/31/2019 $6.74 B 7.74% 1879
12/31/2018 $6.25 B 0.47% 1697
12/29/2017 $6.23 B -19.41% 1967
12/30/2016 $7.73 B -2.05% 1299

Company Profile

About Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company headquartered in Hyderabad, India. Established in 1984, the company operates through its subsidiaries across multiple segments, delivering a wide range of healthcare solutions.

Business Segments

  • Global Generics: Manufactures and markets prescription and over-the-counter pharmaceutical products, including branded generics and biologics.
  • Pharmaceutical Services and Active Ingredients (PSAI): Produces active pharmaceutical ingredients (APIs) and intermediates, along with contract research services.
  • Others: Focuses on innovative therapies in oncology and inflammation, differentiated formulations, digital healthcare, and IT-enabled business support services.

Therapeutic Categories

The company provides products across key therapeutic areas, including:

  • Gastro-intestinal
  • Cardiovascular
  • Anti-diabetic
  • Dermatology
  • Oncology
  • Respiratory
  • Stomatology
  • Urology and Nephrology

Dr. Reddy's Laboratories continues to expand its global footprint, leveraging research, innovation, and high-quality manufacturing to serve patients worldwide.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.